Bifidobacterium longum R0175 Protects Rats against d-Galactosamine-Induced Acute Liver Failure

K Wang, L Lv, R Yan, Q Wang, H Jiang, W Wu, Y Li… - Msphere, 2020 - Am Soc Microbiol
Acute liver failure is a severe liver disorder that poses considerable global challenges.
Previous studies on Bifidobacterium longum R0175 have mainly focused on its psychotropic …

Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in d-galactosamine-treated rats

Y Li, L Lv, J Ye, D Fang, D Shi, W Wu, Q Wang… - Applied microbiology …, 2019 - Springer
Acute liver failure is a drastic, unpredictable clinical syndrome with high mortality. Various
preventive and adjuvant therapies based on modulating the gut flora have been proposed …

Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota

D Fang, D Shi, L Lv, S Gu, W Wu, Y Chen, J Guo… - Scientific Reports, 2017 - nature.com
The gut microbiota is altered in liver diseases, and several probiotics have been shown to
reduce the degree of liver damage. We hypothesized that oral administration of specific …

Multiple Intestinal Bacteria Associated with the Better Protective Effect of Bifidobacterium pseudocatenulatum LI09 against Rat Liver Injury

H Zha, G Si, C Wang, H Zhang… - BioMed Research …, 2022 - Wiley Online Library
Bifidobacterium pseudocatenulatum LI09 could protect rats from D‐galactosamine‐(D‐GalN‐
) induced liver injury. However, individual difference in the protective effects of LI09 on the …

Effect and Mechanism of Bifidobacterium animalis B94 in the Prevention and Treatment of Liver Injury in Rats

T Zhang, J Wang, Z Yao, L Ni, Y Zhao, S Wei… - Frontiers in Cellular …, 2022 - frontiersin.org
Objective To investigate the effect of Bifidobacterium animalis B94 on the prevention and
treatment of liver injury in rats and to elucidate the underlying mechanism of this …

The synergy of dietary supplements Lactobacillus salivarius LI01 and Bifidobacterium longum TC01 in alleviating liver failure in rats treated with D-galactosamine

A Zhuge, S Li, Y Yuan, B Li, L Li - Food & Function, 2021 - pubs.rsc.org
Lactobacillus salivarius (L. salivarius) has been widely used in dietary supplements and
clinical treatments. Previous studies demonstrated the protective effect of L. salivarius LI01 …

Bifidobacterium breve CNCM I-4035, Lactobacillus paracasei CNCM I-4034 and Lactobacillus rhamnosus CNCM I-4036 Modulate Macrophage Gene Expression and Ameliorate …

L Fontana, J Plaza-Díaz, P Robles-Bolívar… - Nutrients, 2021 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) has reached pandemic proportions worldwide. We
have previously reported that the probiotic strains Bifidobacterium breve CNCM I-4035 …

Intestinal microbiomics and hepatic metabolomics insights into the potential mechanisms of probiotic Bifidobacterium pseudolongum CCFM1253 preventing acute …

W Guo, S Cui, X Tang, Y Yan, F Xiong… - Journal of the …, 2023 - Wiley Online Library
BACKGROUND Bifidobacterium pseudolongum is widely exists in mammal gut and its
abundance is associated with human and animal health. The present study aimed to …

Bifidobacterium longum BL-10 with Antioxidant Capacity Ameliorates Lipopolysaccharide-Induced Acute Liver Injury in Mice by the Nuclear Factor-κB Pathway

J Dong, L Ping, Y Meng, K Zhang, H Tang… - Journal of Agricultural …, 2022 - ACS Publications
Bifidobacterium longum is frequently utilized and has broad prospects for preventing liver
injury. The current research assessed the antioxidant capacity of B. longum BL-10 and …

Bifidobacterium longum subsp. longum 51A attenuates intestinal injury against irinotecan-induced mucositis in mice

MF Quintanilha, VC Miranda, RO Souza, B Gallotti… - Life Sciences, 2022 - Elsevier
Intestinal mucositis (IM) is a critical side-effect associated with antineoplastic therapy.
Treatment available is only palliative and often not effective. However, alternative …